Development of an optimized MRI protocol for a rapid preoperative identification of sentinel lymph nodes using superparamagnetic iron oxide - The Gothenburg fast acquisition sentinel lymph node tracking magnetic resonance imaging protocol (GO-FAST-MRI).
Pontus Zaar, Nushin Mirzaei, Oscar Jalnefjord, Erica de Coursey, Iva Johansson, Fredrik Wärnberg, Henrik Leonhardt, Roger Olofsson Bagge
{"title":"Development of an optimized MRI protocol for a rapid preoperative identification of sentinel lymph nodes using superparamagnetic iron oxide - The Gothenburg fast acquisition sentinel lymph node tracking magnetic resonance imaging protocol (GO-FAST-MRI).","authors":"Pontus Zaar, Nushin Mirzaei, Oscar Jalnefjord, Erica de Coursey, Iva Johansson, Fredrik Wärnberg, Henrik Leonhardt, Roger Olofsson Bagge","doi":"10.1016/j.ejso.2024.109362","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Determining sentinel lymph node (SLN) status is important for treatment decisions in patients with melanoma. Superparamagnetic iron oxide nanoparticles (SPIO) combined with MRI have emerged as an alternative to Technetium<sup>99m</sup> lymphoscintigraphy for preoperative mapping of SLN, however, the MRI protocols so far are extensive with long in-camera time. This study aimed to evaluate an optimized MRI protocol for rapid identification of SLNs using SPIO as a tracer, without compromising diagnostic quality, the GOthenburg Fast Acquisition Sentinel lymph node Tracking MRI (GO-FAST-MRI).</p><p><strong>Materials and methods: </strong>In this prospective single-center pilot study, patients with confirmed melanoma on the trunk or limbs, without clinically suspected lymph node metastasis, were eligible. All patients received an injection of 0.1 mL SPIO divided into four quadrants around the scar. The GO-FAST-MRI protocol, using only T1-weighted and Dixon sequences over the axillary or inguinal basins, was conducted no earlier than 30 min post-injection. Technetium and lymphoscintigraphy were used according to routine. SLN-biopsy was performed using a handheld magnetometer and gamma probe for SLN-detection.</p><p><strong>Results: </strong>Twenty-one patients were enrolled, and SLNs were successfully identified in all with both methods. The GO-FAST-MRI protocol was performed in 4 min and detected more SLNs than lymphoscintigraphy (54 vs 42), but the number of SLNs identified during surgery with the magnetometer and gamma probe was the same (50 for both methods). Of the SLNs removed, five were found to have metastases, all of which showed uptake of SPIO and Tc99m.</p><p><strong>Conclusion: </strong>The novel GO-FAST-MRI protocol, with a 4-min scan-time, was feasible in detecting SLNs in all patients. Both the preoperative SLN-mapping and intraoperative SLN-detection using the magnetic technique was comparable to the radioactive technique.</p>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 1","pages":"109362"},"PeriodicalIF":3.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejso.2024.109362","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Determining sentinel lymph node (SLN) status is important for treatment decisions in patients with melanoma. Superparamagnetic iron oxide nanoparticles (SPIO) combined with MRI have emerged as an alternative to Technetium99m lymphoscintigraphy for preoperative mapping of SLN, however, the MRI protocols so far are extensive with long in-camera time. This study aimed to evaluate an optimized MRI protocol for rapid identification of SLNs using SPIO as a tracer, without compromising diagnostic quality, the GOthenburg Fast Acquisition Sentinel lymph node Tracking MRI (GO-FAST-MRI).
Materials and methods: In this prospective single-center pilot study, patients with confirmed melanoma on the trunk or limbs, without clinically suspected lymph node metastasis, were eligible. All patients received an injection of 0.1 mL SPIO divided into four quadrants around the scar. The GO-FAST-MRI protocol, using only T1-weighted and Dixon sequences over the axillary or inguinal basins, was conducted no earlier than 30 min post-injection. Technetium and lymphoscintigraphy were used according to routine. SLN-biopsy was performed using a handheld magnetometer and gamma probe for SLN-detection.
Results: Twenty-one patients were enrolled, and SLNs were successfully identified in all with both methods. The GO-FAST-MRI protocol was performed in 4 min and detected more SLNs than lymphoscintigraphy (54 vs 42), but the number of SLNs identified during surgery with the magnetometer and gamma probe was the same (50 for both methods). Of the SLNs removed, five were found to have metastases, all of which showed uptake of SPIO and Tc99m.
Conclusion: The novel GO-FAST-MRI protocol, with a 4-min scan-time, was feasible in detecting SLNs in all patients. Both the preoperative SLN-mapping and intraoperative SLN-detection using the magnetic technique was comparable to the radioactive technique.
前言:确定前哨淋巴结(SLN)状态对黑色素瘤患者的治疗决策很重要。超顺磁性氧化铁纳米颗粒(SPIO)结合MRI已成为术前SLN定位的Technetium99m淋巴显像的替代方案,然而,迄今为止MRI方案广泛且相机时间长。本研究旨在评估一种优化的MRI方案,在不影响诊断质量的情况下,使用SPIO作为示踪剂快速识别sln,即哥德堡快速采集前哨淋巴结跟踪MRI (GO-FAST-MRI)。材料和方法:在这项前瞻性单中心试点研究中,已确诊的躯干或四肢黑色素瘤,临床未怀疑淋巴结转移的患者纳入研究对象。所有患者均在瘢痕周围注射0.1 mL SPIO,分为四个象限。GO-FAST-MRI方案仅在腋窝或腹股沟盆地上使用t1加权和Dixon序列,不早于注射后30分钟进行。常规采用锝和淋巴显像。sln活检使用手持式磁强计和伽玛探针进行sln检测。结果:共纳入21例患者,两种方法均成功识别sln。GO-FAST-MRI方案在4分钟内完成,比淋巴显像检测到更多的sln(54比42),但手术期间用磁强计和伽马探头识别的sln数量相同(两种方法各50个)。在切除的sln中,发现有5例转移,均表现为摄取SPIO和Tc99m。结论:新的GO-FAST-MRI方案,扫描时间为4分钟,在所有患者中检测sln是可行的。术前sln定位和术中使用磁性技术的sln检测与放射性技术相当。
期刊介绍:
JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery.
The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.